About J-GLOBAL

日本語

Font size
  • A
  • A

Articleの詳細情報

ArticleJ-GLOBAL ID:200902076571510357整理番号:91A0183705

新規α1受容体遮断薬YM617の臨床第I相試験 第1報:健康成人男子における乳糖倍散単回経口投与試験

Phase I clinical trial of YM617, a new .ALPHA.1 adrenoceptor antagonist. First report: A single oral dose of conventional formulation in healthy male subjects.

著者:角尾道夫(鳳川診療所)、宍戸亮(鳳川診療所)、添石良あき(山之内製薬開発薬理研)・・・
資料名:臨床医薬 巻:6 号:12 ページ:2503-2528
発行年:1990年12月
  • J-GLOBAL home
  • Bookmark J-GLOBAL

J-GLOBAL: Linking, Expanding and Sparking

About J-GLOBAL

Linking

J-GLOBAL links information that represents the key to research and development. For example, linking articles and patents with people (authors and inventors) enables the extraction of a sequence of information.
It’s useful for making new discoveries and uncovering new information.

Expanding

The system enables searches of similar kinds of content through linkage with external sites.
It helps you to obtain knowledge from dissimilar fields and discover concepts that cross the boundaries of specialisms.

Sparking

Through repeated linkage and expansioniteration, J-GLOBAL provides unexpected hints for problem-solving and the illumination of new ideas.